✨ Tariff and Therapeutic Drug Notices
3544
THE NEW ZEALAND GAZETTE
No. 152
Tariff Notice No. 1984/180—Application for Variation of Determination—continued
The identification reference to the application number indicates the office to which any objections should be made.
H.O.—Comptroller of Customs, Private Bag, Wellington.
Any person wishing to lodge an objection to the granting of this application should do so in writing to the appropriate office as indicated by the identification reference on or before 20 September 1984. Submissions should include a reference to the identification reference, application number, Tariff Item, and description of goods concerned and be supported by information as to:
(a) The range of equivalent goods manufactured locally;
(b) The proportion of New Zealand and imported material used in manufacture;
(c) Present and potential output; and
(d) Details of factory cost in terms of materials, labour, overhead, etc.
Dated at Wellington this 30th day of August 1984.
P. J. MCKONE, Comptroller of Customs.
Consent to the Distribution of New Therapeutic Drugs
PURSUANT to section 12 of the Food and Drug Act 1969, the Minister of Health hereby consents to the distribution in New Zealand of the new therapeutic drugs set out in the Schedule hereto.
SCHEDULE
Name of Drug Form Active Ingredients (as listed on label) Name of Manufacturer Address
M.V.I.-12 Infusion (Vials) Vitamins A, B, C and D plus Biotin. Folic Acid and Vitamin B12 USV Pharmaceutical Corp. U.S.A.
Protect Gel Toothpaste (Sodium Citrate 1.5% w/w Chem Industries Ltd. New Zealand
Diane Tablet (Citric Acid 0.5% w/w Schering AG Berlin West Germany
(Cyproterone Acetate 2.0 mg
(Ethinylestradiol 0.05 mg
Dated this 21st day of August 1984.
MICHAEL BASSETT, Minister of Health.
Consent to the Distribution of New Therapeutic Drugs
PURSUANT to section 12 of the Food and Drug Act 1969, the Minister of Health hereby consents to the distribution in New Zealand of the new therapeutic drugs set out in the Schedule hereto.
SCHEDULE
Name of Drug Form Active Ingredients (as listed on label) Name of Manufacturer Address
Nitepam Tablet Nitrazepam 5 mg Berk Pharmaceuticals Ltd. United Kingdom
Xanax Tablet Alprazolam 0.25 mg, 0.5 mg and 1.0 mg Upjohn S.A. or The Upjohn Co. U.S.A.
Quens Tablet Pyridoxine Hydrochloride 50 mg Chem Industries Ltd. New Zealand
E-Z-HD Powder Barium Sulphate U.S.P. E-Z-EM Co. Inc. U.S.A.
ACB-Polibar Powder Barium Sulphate U.S.P. E-Z-EM Co. Inc. U.S.A.
Liquid Polibar Suspension Barium Sulphate U.S.P. E-Z-EM Co. Inc. U.S.A.
HD-Gias Granules (Sodium Bicarbonate U.S.P. 53.47% w/w Tower Laboratories Ltd. U.S.A.
(Citric Acid U.S.P. 39.95% w/w
Saliva Substitute Liquid (Sorbitol Solution U.S.P. 4.275% w/v Philips Roxane Inc. U.S.A.
(Sodium Carboxymethylcellulose 1.00% w/v
M.V.I. Concentrate Infusion (Vial) Vitamins A, B, C and D USV Pharmaceutical Corp. U.S.A.
Dated this 21st day of August 1984.
MICHAEL BASSETT, Minister of Health.
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1984, No 152
NZLII —
NZ Gazette 1984, No 152
✨ LLM interpretation of page content
🏭
Application for Variation of Tariff Determination
(continued from previous page)
🏭 Trade, Customs & Industry30 August 1984
Tariff, Variation, Determination, Objections, Customs Duty
- P. J. McKone, Comptroller of Customs
🏥 Consent to Distribution of New Therapeutic Drugs
🏥 Health & Social Welfare21 August 1984
Therapeutic Drugs, Distribution, Food and Drug Act, Vitamins, Medication
- Michael Bassett, Minister of Health
🏥 Consent to Distribution of New Therapeutic Drugs
🏥 Health & Social Welfare21 August 1984
Therapeutic Drugs, Distribution, Food and Drug Act, Medication, Pharmaceuticals
- Michael Bassett, Minister of Health